Traditional clinical trial models are outdated and causes multiple issues for patients, trial sites, and sponsors. These issues are predominantly related to low patient recruitment and retention rates, leading to trial delays and high costs. Decentralized trials (DCTs) offer an innovative solution to these problems by improving patient experiences and satisfaction with the use of digital technologies and other remote services, as well as bringing the research closer to the patient.
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has publishedRead more